Hrt Financial LP Pulmonx Corp Transaction History

Hrt Financial LP

  • $17 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$7.89 - $13.14 $15,401 - $25,649
1,952 Added 19.15%
12,144 $154,000
Q3 2023

Nov 13, 2023
SELL
$9.88 - $14.0 $854,649 - $1.21 Million
-86,503 Reduced 89.46%
10,192 $105,000
Q2 2023

Aug 11, 2023
BUY
$10.78 - $13.65 $1.04 Million - $1.32 Million
96,695 New
96,695 $1.27 Million
Q4 2022

Feb 10, 2023
BUY
$4.92 - $17.35 $318,653 - $1.12 Million
64,767 New
64,767 $545,000

Others Institutions Holding LUNG

# of Institutions
116
Shares Held
30.6M
Call Options Held
400
Put Options Held
0
View Full List

About Pulmonx Corp

LUNG Quotes by TradingView
  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $309M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email